{"TopicDetails": {"type": 0, "ccm2Id": 45149159, "cftId": 0, "identifier": "ISF-2022-TF1-AG-DRUGS", "title": "DRUGS", "publicationDateLong": 1655769600000, "callIdentifier": "ISF-2022-TF1-AG-DRUGS", "callTitle": "Call for proposals on better law enforcement in the area of illicit drug trafficking and on support to demand-focused initiatives in the fields of drug policy", "callccm2Id": 45149169, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43252368, "abbreviation": "ISF", "description": "Internal Security Fund (ISF)"}, "programmeDivision": [{"id": 44477772, "abbreviation": "ISF-2-4", "description": "Drugs"}], "topicMGAs": [], "tags": ["Drugs", "Cannabis", "Meth", "Cocaine"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "ISF-PJG ISF Project Grants", "typeOfMGA": [{"id": 43250150, "abbreviation": "ISF-AG", "description": "ISF Action Grant Budget-Based"}]}], "plannedOpeningDate": "21 June 2022", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["04 October 2022"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3414152": [{"action": "ISF-2022-TF1-AG-DRUGS - ISF-PJG ISF Project Grants", "plannedOpeningDate": "21 June 2022", "deadlineModel": "single-stage", "deadlineDates": ["04 October 2022"], "budgetYearMap": {"2022": 3000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2022"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Call on better law enforcement in the area of illicit drug trafficking</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">&nbsp;</p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;</span><span style=\"background-color: rgb(198, 219, 239); font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px;\">described in section 5 of the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a><span style=\"background-color: rgb(198, 219, 239); font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px;\">&nbsp;and described in Part B of the Application Form available in the Submission System.</span></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">Part B&nbsp;<u>without</u>&nbsp;annexes is limited to maximum 50 pages.</p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">&nbsp;</p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">List of previous projects to be submitted&nbsp;<u>as a separate annex</u>.</p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the&nbsp;</span><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the&nbsp;</span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the&nbsp;<a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a>&nbsp;and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the&nbsp;</span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the&nbsp;</span></span><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\"><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">call document</a></span><a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/isf/wp-call/2021-2022/call-fiche_isf-2022-tf1-ag-drugs_en.pdf\" target=\"_blank\">&nbsp;</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/temp-form/af/af_amif-isf-bmvi_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Standard application form</a>&nbsp;</span><span style=\"color: rgb(64, 64, 64);\">&mdash;</span><i><span style=\"color: rgb(64, 64, 64);\">&nbsp;<span lang=\"EN-US\">call-specific application form is available in the Submission System</span></span></i><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span style=\"color: rgb(64, 64, 64);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_amif-isf-bmvi_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">AMIF, ISF and BMVI MGA v1.0</a></span></p>\r\n<p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/home-affairs/funding/internal-security-funds/internal-security-fund-2021-2027_en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; font-family: Arial, Verdana, sans-serif; font-size: 12px;\"><span lang=\"EN-US\" style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; color: rgb(64, 64, 64);\">ISF</span><span class=\"MsoHyperlink\" style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px;\"><span style=\"color: rgb(64, 64, 64);\">&nbsp;Work Programme 2021-2022</span></span></a><span style=\"color: rgb(64, 64, 64);\">&nbsp;</span></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32021R1149&amp;qid=1632207915919&amp;from=en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">ISF</a></span><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32021R1149&amp;qid=1632207915919&amp;from=en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">&nbsp;Regulation (EU) 2021/1149</a><br />\r\n</span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; color: rgb(40, 151, 183); text-decoration-line: none;\"><span lang=\"EN-US\">EU Financial Regulation 2018/1046</span></a></p>\n", "supportInfo": "<table style=\"margin: 0px; width: 1384.94px; border-width: 0px; border-style: initial; border-color: initial; color: rgb(0, 0, 0); font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">\r\n    <tbody>\r\n        <tr>\r\n        </tr>\r\n        <tr>\r\n            <td style=\"padding: 2px;\">\r\n            <p style=\"padding: 3px 0px; margin: 0px; line-height: 1.5;\"><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span></p>\r\n            <p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n            <p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n            <p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>\r\n            <p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: normal;\"><span style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px;\">HOME-ISF@ec.europa.eu - For non-IT related questions and assistance related to content of the call/topics.</span></p>\r\n            </td>\r\n        </tr>\r\n    </tbody>\r\n</table>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 21, 2022 12:00:00 AM", "lastChangeDate": "Jun 21, 2022 12:00:00 AM", "content": "The submission session is now available for: ISF-2022-TF1-AG-DRUGS(ISF-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}